DE1620533A1 - Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz[b,f][14]oxazepin-11(1OH)-onen - Google Patents

Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz[b,f][14]oxazepin-11(1OH)-onen

Info

Publication number
DE1620533A1
DE1620533A1 DE19661620533 DE1620533A DE1620533A1 DE 1620533 A1 DE1620533 A1 DE 1620533A1 DE 19661620533 DE19661620533 DE 19661620533 DE 1620533 A DE1620533 A DE 1620533A DE 1620533 A1 DE1620533 A1 DE 1620533A1
Authority
DE
Germany
Prior art keywords
dibenz
radicals
substituted
acid
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661620533
Other languages
German (de)
English (en)
Inventor
Dr Hans Klupp
Dr Hans Machleidt
Dr Guenther Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of DE1620533A1 publication Critical patent/DE1620533A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19661620533 1966-01-28 1966-01-28 Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz[b,f][14]oxazepin-11(1OH)-onen Pending DE1620533A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET0030351 1966-01-28

Publications (1)

Publication Number Publication Date
DE1620533A1 true DE1620533A1 (de) 1970-04-16

Family

ID=7555526

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661620533 Pending DE1620533A1 (de) 1966-01-28 1966-01-28 Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz[b,f][14]oxazepin-11(1OH)-onen

Country Status (10)

Country Link
US (1) US3544561A (US20030204162A1-20031030-M00001.png)
BE (1) BE693333A (US20030204162A1-20031030-M00001.png)
CH (1) CH481937A (US20030204162A1-20031030-M00001.png)
DE (1) DE1620533A1 (US20030204162A1-20031030-M00001.png)
DK (1) DK120638B (US20030204162A1-20031030-M00001.png)
ES (4) ES336172A1 (US20030204162A1-20031030-M00001.png)
FR (2) FR6377M (US20030204162A1-20031030-M00001.png)
GB (1) GB1170322A (US20030204162A1-20031030-M00001.png)
NL (2) NL6700603A (US20030204162A1-20031030-M00001.png)
SE (1) SE330890B (US20030204162A1-20031030-M00001.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2024040C (en) * 1989-08-29 2002-02-19 Karl D. Hargrave Dibenz [b,f] [1,4]oxazepin (and thiazepin)-11 (10h)-ones and-thiones and their use in the prevention or treatment of aids
GB9021813D0 (en) * 1990-10-08 1990-11-21 Ici Plc Tricyclic heterocycles
US5180720A (en) * 1991-05-03 1993-01-19 G. D. Searle & Co. 2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain
US5378840A (en) * 1992-04-16 1995-01-03 G. D. Searle & Co. Substituted dibenzoxazepine compounds
US5182272A (en) * 1991-05-03 1993-01-26 G. D. Searle & Co. 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain
GB9120640D0 (en) * 1991-09-27 1991-11-06 Ici Plc Tricyclic heterocycles
US5212169A (en) * 1991-10-31 1993-05-18 G. D. Searle & Co. Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain
US5449674A (en) * 1991-11-05 1995-09-12 G. D. Searle & Co. 2-,3-,5-, and/or 8-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain
AU3143593A (en) * 1991-12-20 1993-07-28 G.D. Searle & Co. Substituted dibenzoxazepines or dibenzothiazepines and their use as prostaglandin E2 antagonists
US5304644A (en) * 1992-04-15 1994-04-19 G. D. Searle & Co. 1-,2-,3-,4-,5-,6-,7-,8- and/or 9 substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain
US5449673A (en) * 1992-08-13 1995-09-12 G. D. Searle & Co. 10,11-dihydro-10-(3-substituted-1-oxo-2-propyl, propenyl or propynyl)dibenz[b,f][1,4] oxazepine prostaglandin antagonists
US5395932A (en) * 1993-04-30 1995-03-07 G. D. Searle & Co. 2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5354746A (en) * 1993-06-01 1994-10-11 G. D. Searle & Co. Squaric acid derivatives of substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5461047A (en) * 1993-06-16 1995-10-24 G. D. Searle & Co. 2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
US5354747A (en) * 1993-06-16 1994-10-11 G. D. Searle & Co. 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
US5424424A (en) * 1993-10-07 1995-06-13 G. D. Searle & Co. Tartaric acid derivatives of substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5420270A (en) * 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5488046A (en) * 1993-11-03 1996-01-30 G. D. Searle & Co. Carbamic acid derivatives of substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5449675A (en) * 1994-06-09 1995-09-12 G. D. Searle & Co. Substituted dibenzoxazepine and dibenzthiazepine urea compounds, pharmaceutical compositions and methods of use
US5441950A (en) * 1994-06-09 1995-08-15 G. D. Searle & Co. Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use
EP1027337A4 (en) * 1997-09-04 2002-04-03 Smithkline Beecham Corp Integrin receptor Antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1060786A (en) * 1963-10-09 1967-03-08 Wander Ag Dr A Process for the preparation of lactams
US3337563A (en) * 1964-09-04 1967-08-22 Upjohn Co 2-amino-2, 3-dihydro-3-substituted-naphtho[1, 2-b]furan-5-ols
US3451776A (en) * 1965-01-18 1969-06-24 Pullman Inc Halogen production

Also Published As

Publication number Publication date
US3544561A (en) 1970-12-01
ES336171A1 (es) 1968-04-01
ES336170A1 (es) 1968-04-01
DK120638B (da) 1971-06-28
NL6700603A (US20030204162A1-20031030-M00001.png) 1967-07-31
CH481937A (de) 1969-11-30
BE693333A (US20030204162A1-20031030-M00001.png) 1967-07-27
FR1510324A (fr) 1968-01-19
ES336173A1 (es) 1968-04-01
NL127795C (US20030204162A1-20031030-M00001.png)
SE330890B (US20030204162A1-20031030-M00001.png) 1970-12-07
GB1170322A (en) 1969-11-12
ES336172A1 (es) 1968-04-01
FR6377M (US20030204162A1-20031030-M00001.png) 1968-10-14

Similar Documents

Publication Publication Date Title
DE1620533A1 (de) Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz[b,f][14]oxazepin-11(1OH)-onen
DE2756113A1 (de) Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0148440B1 (de) 1,3,4,5-Tetrahydrobenz[c,d]indole, ein Verfahren zu ihrer Herstellung und ihre Verwendung
CH650782A5 (de) Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DE102007034620A1 (de) Neue B1-Antagonisten
EP0271040A2 (de) Neue Pyrrolobenzimidazole, Verfahren zu ihrer Herstellung, sowie Arzneimittel
DE1810423A1 (de) 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dione und Verfahren zu ihrer Herstellung
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2628189A1 (de) 3-phenylindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0056144A1 (de) Neue Carbonsäure-Derivate, ihre Herstellung und ihre Verwendung als Arzneimittel
WO1988001268A1 (en) Imidazole derivatives
Neumeyer et al. Isoquinolines. 3. 3-Aminoisoquinoline derivatives with central nervous system depessant activity
DE3132915A1 (de) 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO2009021945A1 (de) Arylsulfonamide mit analgetischer wirkung
DE3688161T2 (de) Gegebenenfalls etherifizierte oder esterifizierte in Stellung 2 substituierte 4-OH-Chinolincarbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende Zubereitungen.
DE3879378T2 (de) Amid-verbindungen.
DK149364B (da) Analogifremgangsmaade til fremstilling af 5-(chlorphenyl)-6h-1,3,4-thiadiazin-2-aminer
EP0025501B1 (de) Neue N-Aminoalkylindol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE602005004024T2 (de) Indol-2-onderivate zur behandlung von erkrankungen des zentralen nervensystems, erkrankungen des magen-darm-trakts und herzkreislauferkankungen
EP0066774A1 (de) Neue 1,4,9,10-Tetrahydro-pyrazolo(4,3-e)pyrido(3,2-b)(1,4)-diazepin-10-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH639389A5 (de) 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
AT274822B (de) Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz[b,f] [1,4]oxazepin-11(10H)-onen sowie von ihren physiologisch verträglichen Säureadditionssalzen
EP0289881A2 (de) Neue 2-Aminoalkyl-4-bennzyl-1-(2H)-phthalazinon-Derivate
DE3225155A1 (de) Neue n-benzylamide und deren salze, ihre herstellung und diese verbindungen enthaltende arzneimittel